PROVIDER PROFILE · NPI 1790724797

Luanne BianchiPA

Physician AssistantRochester, NYI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

694

Beneficiaries

—

Total drug cost

$16K

Distinct drugs

Brand share

2.2%

Top prescribed drugs

Gabapentin148 claims

Pregabalin82 claims

Baclofen72 claims

Duloxetine Hcl58 claims

Celecoxib49 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$629

Payment records

By payment type

Food and Beverage$629

REFERRAL NETWORK

Where Luanne Bianchi's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 13 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
ROCHESTER GENERAL HOSPITAL	110	274
Frank Skurpski Internal Medicine · Rochester, NY	35	49
National Ambulance & Oxygen Service, Inc. Ambulance Service Provider · Rochester, NY	31	50
Hyun Yoo Internal Medicine · Rochester, NY	30	40
UNIVERSITY OF ROCHESTER	25	60
MACDONALD, IMELDA	22	32
George Paz Internal Medicine · Rochester, NY	19	59
Edward Zinkin Diagnostic Radiology · Rochester, NY	19	28
Arthur Pellittieri Internal Medicine · The Villages, FL	18	23
Meghan Single Diagnostic Radiology · Rochester, NY	15	20
Bryan Scott Diagnostic Radiology · Rochester, NY	15	21
Parul Patel Diagnostic Radiology · Rochester, NY	13	19

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history